Type your tag names separated by a space and hit enter

Special Dosing Considerations

Special Dosing Considerations is a topic covered in the Davis's Drug Guide.

To view the entire topic, please or purchase a subscription.

Emergency Central is a collection of disease, drug, and test information including 5-Minute Emergency Medicine Consult, Davis’s Drug, McGraw-Hill Medical’s Diagnosaurus®, Pocket Guide to Diagnostic Tests, and MEDLINE Journals created for emergency medicine professionals. Explore these free sample topics:

Emergency Central

-- The first section of this topic is shown below --

General

For many patients the average dose range for a given drug can be toxic. The purpose of this section is to describe vulnerable patient populations for which special dosing considerations must be made to protect the patient and improve clinical outcomes.

-- To view the remaining sections of this topic, please or purchase a subscription --

Citation

Quiring, Courtney, et al. "Special Dosing Considerations." Davis's Drug Guide, 16th ed., F.A. Davis Company, 2019. Emergency Central, emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/109953/all/Special_Dosing_Considerations.
Quiring C, Sanoski CA, Vallerand AH. Special Dosing Considerations. Davis's Drug Guide. 16th ed. F.A. Davis Company; 2019. https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/109953/all/Special_Dosing_Considerations. Accessed March 20, 2019.
Quiring, C., Sanoski, C. A., & Vallerand, A. H. (2019). Special Dosing Considerations. In Davis's Drug Guide. Available from https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/109953/all/Special_Dosing_Considerations
Quiring C, Sanoski CA, Vallerand AH. Special Dosing Considerations [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2019. [cited 2019 March 20]. Available from: https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/109953/all/Special_Dosing_Considerations.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Special Dosing Considerations ID - 109953 A1 - Quiring,Courtney, AU - Sanoski,Cynthia A, AU - Vallerand,April Hazard, BT - Davis's Drug Guide UR - https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/109953/all/Special_Dosing_Considerations PB - F.A. Davis Company ET - 16 DB - Emergency Central DP - Unbound Medicine ER -